<DOC>
	<DOCNO>NCT02984475</DOCNO>
	<brief_summary>Beta Thalassemia major public health problem Mediterranean countries.In Egypt , consider common chronic hemolytic anemia.one major complication inherit disorder iron overload lead oxidative stress tissue damage . Regarding toxic effect iron overload liver , hepatomegaly one finding result hemosiderosis , extra medullary hematopoiesis , transmit hepatitis B C cirrhosis . A lot study carry recently study beneficial role metformin non-diabetic patient different disorder non-alcoholic fatty liver disease ( NAFLD ) .Among several study , 's demonstrate metformin significantly improve insulin resistance , aminotransferase level liver morphology . The role metformin study mainly think antioxidant anti-inflammatory effect . However , role Metformin hepatic function different population mechanism liver injury investigate . This clinical trial carry 60 patient beta thalassemia major receive regular blood transfusion iron chelate therapy , either HCV positive negative patient . They randomly distribute either control group ( group 1 , n=30 ) receive blood transfusion take iron chelate therapy treatment group ( group 2 , n=30 ) receive blood transfusion take iron chelate therapy along metformin tablet ( 500 mg/twice daily ) 6 month .</brief_summary>
	<brief_title>The Potential Hepatoprotective Effect Metformin Patients With Beta Thalassemia Major</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diagnosed BetaThalassemia Major receive regular blood transfusion iron chelate therapy . Weight : equal 35 kg . Normal renal function . Patients renal impairment ( serum creatinine twice upper limit normal ) . Patients heart failure . Patients sepsis active infection . Patients diabetes mellitus ( either primary secondary thalassemia ) . regular consumption medication potential hepatotoxicity . regular herbal medicine antioxidant supplementation . patient gastrointestinal condition prevent adsorption oral medication .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Beta Thalassemia</keyword>
	<keyword>Metformin</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Iron overload</keyword>
	<keyword>Liver function</keyword>
</DOC>